Analysts expect Ovid Therapeutics Inc. to report revenue of 21,268.38 for Q3 26, against a range of 19,212.56 to 23,324.20. The most recent reported quarter, Q2 26, came in at 733,000.00 , in line with the 20,171.09 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 173,000.00 | 76,000.00 | 130,000.00 | 6.27 M | 132,000.00 | 718,000.00 | 0.00 | 733,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 119,520.48 | 212,448.64 | 49,554.59 | 107,860.42 | 215,749.33 | 87,393.98 | 58,354.66 | 21,183.44 | 23,324.20 | 110,632.47 | 50,962.49 | 282,409.46 | -1.27 M | -396,993.91 | 589,308.09 | 1.27 M | ||||||||||
| Low Estimate | 103,103.52 | 186,736.34 | 46,040.97 | 97,489.62 | 181,719.99 | 76,112.52 | 51,922.32 | 19,158.74 | 19,212.56 | 102,060.11 | 45,219.01 | 241,228.96 | -1.39 M | -457,526.43 | 530,869.55 | 1.09 M | ||||||||||
| Consensus Estimate | 111,312.00 | 199,592.49 | 47,797.78 | 102,675.02 | 198,734.66 | 81,753.25 | 55,138.49 | 20,171.09 | 21,268.38 | 106,346.29 | 48,090.75 | 261,819.21 | -1.33 M | -427,260.17 | 560,088.82 | 1.18 M |
Analysts expect Ovid Therapeutics Inc. to report earnings per share of -0.09 for Q3 26, against a range of -0.10 to -0.08. The most recent reported quarter, Q2 26, came in at -0.08, a 33.3% beat against the -0.12 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.20 | -0.13 | -0.14 | -0.06 | -0.17 | 0.06 | -0.12 | -0.08 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.21 | -0.17 | -0.12 | -0.16 | -0.14 | -0.10 | -0.10 | -0.11 | -0.08 | -0.09 | -0.08 | -0.09 | -0.10 | -0.05 | -0.11 | -0.11 | ||||||||||
| Low Estimate | -0.23 | -0.19 | -0.14 | -0.18 | -0.16 | -0.12 | -0.12 | -0.13 | -0.10 | -0.09 | -0.10 | -0.11 | -0.10 | -0.07 | -0.13 | -0.13 | ||||||||||
| Consensus Estimate | -0.22 | -0.18 | -0.13 | -0.17 | -0.15 | -0.11 | -0.11 | -0.12 | -0.09 | -0.09 | -0.09 | -0.10 | -0.10 | -0.06 | -0.12 | -0.12 |